FromAstraZeneca ([email protected])
Subject (39)Update on anselamimab in AL amyloidosis
Preheader (86)Update on CARES Phase III clinical programme of anselamimab in light chain amyloidosis
Arial
Text Analysis
Body Words164
Subject Words6
Body Emojis1
Subject Emojis
Media Analysis
Text Links8
Image Links4
Total Links12
Images6
Technical Metrics
Performance
HTML Size, Kb
Pixel Length, px798 px
X-Spam Score1.0
Preheader OptimizedNo
Timing
Day of WeekThursday
TimeMorning
